Healthcare stocks rose late Monday afternoon with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding 0.3%.
In corporate news, Eli Lilly (LLY) plans to pursue larger pharmaceutical deals as it looks to expand into new therapeutic areas, Bloomberg reported, citing an interview with CEO David Ricks on the sidelines of a diabetes conference in Milan. Ricks cited infectious disease, women's health, and psychiatric conditions as possible areas of opportunity in a broadening search for pharmaceutical deals, the report said. Lilly shares were up 0.4%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.